Big pharma’s search for a COVID-19 vaccine: Take It To The Limit

The 2020 COVID-19 pandemic undermines the world economy, the affordability and accessibility of our health systems. It puts an increasing strain on global production, supply and value chains. The research and development of a set of COVID-19 vaccines is an unprecedented triumph of rapid innovation....

Full description

Saved in:
Bibliographic Details
Published in:Journal of innovation management (Porto) 2021-08, Vol.9 (2), p.I-VII
Main Authors: Segers, Jean-Pierre, Gaile-Sarkane, Elina
Format: Article
Language:English
Subjects:
Access
Affordability
biopharmaceutical
Biotechnology
Business
Business & economic sciences
business model
COVID-19
covid-19 - biopharmaceuticals
COVID-19 vaccines
Global economy
Health care
Innovations
Pandemics
Pharmaceutical industry
Prescription drugs
R&D
Research & development
Research centers
Sciences économiques & de gestion
Severe acute respiratory syndrome coronavirus 2
Strategy & innovation
Stratégie & innovation
Urgency
Vaccines
Value chain
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The 2020 COVID-19 pandemic undermines the world economy, the affordability and accessibility of our health systems. It puts an increasing strain on global production, supply and value chains. The research and development of a set of COVID-19 vaccines is an unprecedented triumph of rapid innovation. The sense of urgency has prompted academic research institutions, big pharmaceuticals and dedicated biotechnology companies to develop vaccines targeting the SARS-CoV-2 coronavirus disease. Simultaneously, it unlocks new value for business, patients and society. Consequently, new business models have come to the forefront.
ISSN:2183-0606
2183-0606
DOI:10.24840/2183-0606_009.002_0001